TDR: TEDCO grant to help fund stem cell research at Johns Hopkins Medicine
Source: External source
The grant will go toward Longeveron’s clinical trial examining the safety and efficacy of its allogeneic mesenchymal stem cell product to improve flu vaccine immune-response in elderly patients with frailty.
Posted May 22, 2018
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com